Teleflex Incorporated (NYSE: TFX) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $6.3B. The Maz Rating grades it against the other companies in its sector.
Teleflex Incorporated's current Maz Rating and its five factor grades are for members: log in to see them.
At $159.60, Teleflex Incorporated trades at 19.2x trailing earnings, 2.8x sales and 1.9x book value, with an EV/EBITDA of 23.7. Over the last twelve months it generated about $2.2B of revenue and $329M of net income. It runs a gross margin of 58.3%, an operating margin of 9.9% and a net margin of 13.6%. It shows return on equity of 9.7%, return on invested capital of 3.2% and a free cash flow yield of 6.1%. On the balance sheet: a debt-to-equity ratio of 0.48 and a current ratio of 2.01. Over the past 52 weeks the share price ranged from $100.18 to $161.00, with a beta of 0.83.
Teleflex Incorporated pays a dividend yielding 0.85%, with 19% of earnings paid out. Its Maz Dividend Score is 1.83 out of 5, ranked against the other dividend payers in its sector (Safety 2.63, Growth 1.63, Yield 2.70, Consistency 3.27).
29 Wall Street analyst ratings cover the stock: 16 Buy and 13 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.